CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
ProDNA-Nano aims to develop a cell-free DNA-based system for the quantification of cancer-related proteins using electrochemical and optical methods. This innovative approach seeks to simplify and reduce the cost of cancer diagnostics.
WHY:
The detection of specific proteins that are overexpressed in different types of cancers is critical for early diagnosis and targeted cancer screening.
Existing methods for quantifying these clinically-relevant proteins, including the enzyme-linked immunosorbent assay (ELISA), have the disadvantage of being a multi-step, reagent-intensive and laboratory-bound process which result in relatively high costs, limiting its applicability at the point of care.
To overcome these limitations, new met…
UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.